Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | ES009 |
Trade Name | |
Synonyms | ES 009|ES-009 |
Drug Descriptions |
ES009 is a monoclonal antibody that targets LILRB2 (ILT4), which may promote a pro-inflammatory state and increase anti-tumor immune response (Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ES009 | ES009 | 0 | 1 |